This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Macular Degeneration  • Psychiatry  • Stress  • Quality of Life  • Alert me on articles by topic

Rebecca A. Williams, PhD; Barbara L. Brody, MPH; Ronald G. Thomas, PhD; Robert M. Kaplan, PhD; Stuart I. Brown, MD

Arch Ophthalmol. 1998;116:514-520.

Background  Age-related macular degeneration (AMD), the leading cause of irreversible blindness and low vision among the elderly, has not been well studied with regard to its impact on daily life. This study was designed to demonstrate the impact of AMD on quality of life, emotional distress, and functional level.

Participants  The study sample consisted of 86 elderly adults (average age, 79 years) with AMD who were legally blind in at least 1 eye. Participants completed a battery of measures that included the Quality of Well-being Scale, the Instrumental Activities of Daily Living index, self-rated general health status, and the Profile of Mood States.

Results  Persons with AMD experienced significant reductions in key aspects of daily life. Their ratings for quality of life (average Quality of Well-being Scale score=0.581) and emotional distress (average Profile of Mood States total score=65.36) were significantly worse than those for similarly aged community adults and were comparable with those reported by people with chronic illnesses (eg, arthritis, chronic obstructive pulmonary disease, acquired immunodeficiency syndrome, and bone marrow transplants). Patients with AMD were also more likely than a national sample of elderly individuals to need help with daily activities. Visual acuity was related to ability to carry out daily activities (Instrumental Activities of Daily Living, r=0.28, P=.008). Quality of life ratings were significantly related to the ability to carry out daily activities (r=-0.38, P=.001), self-rated general health status (r=-0.21, P=.05), and emotional distress (Profile of Mood States total score, r=-0.25, P=.02). Individuals with a shorter period of perceived vision loss were more likely to report high levels of emotional distress (r=-0.24, P=.03) than those with a longer period of perceived vision loss. Further, those who were blind in 1 eye were even more significantly distressed than those who were blind in both eyes.

Conclusions  Elderly persons with AMD causing legal blindness in 1 or both eyes have significant emotional distress and profoundly reduced quality of life and need help with key daily activities.

From the Department of Ophthalmology, Shiley Eye Center (Drs Williams and Brown and Ms Brody); Department of Family & Preventive Medicine, Division of Health Care Sciences (Ms Brody, Drs Thomas and Kaplan), School of Medicine, and the Department of Neurosciences (Dr Thomas), University of California, San Diego, La Jolla.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Patterns of ophthalmological complaints presenting to a dedicated ophthalmic Accident & Emergency department: inappropriate use and patients' perspective
Hau et al.
Emerg. Med. J. 2008;25:740-744.
ABSTRACT | FULL TEXT  

Improved Vision-Related Function After Ranibizumab Treatment of Neovascular Age-Related Macular Degeneration: Results of a Randomized Clinical Trial
Chang et al.
Arch Ophthalmol 2007;125:1460-1469.
ABSTRACT | FULL TEXT  

Formal and informal care utilisation amongst elderly persons with visual impairment
Ke et al.
Br. J. Ophthalmol. 2007;91:1279-1281.
ABSTRACT | FULL TEXT  

Intravitreal Infliximab and Choroidal Neovascularization in an Animal Model
Olson et al.
Arch Ophthalmol 2007;125:1221-1224.
ABSTRACT | FULL TEXT  

Burden and Health Care Resource Utilization in Neovascular Age-Related Macular Degeneration: Findings of a Multicountry Study
Soubrane et al.
Arch Ophthalmol 2007;125:1249-1254.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life and Utility in Patients With Age-Related Macular Degeneration
Sahel et al.
Arch Ophthalmol 2007;125:945-951.
ABSTRACT | FULL TEXT  

Impact of age related macular degeneration on quality of life
Hassell et al.
Br. J. Ophthalmol. 2006;90:593-596.
ABSTRACT | FULL TEXT  

The Impact of Age-Related Macular Degeneration on Health Status Utility Values
Espallargues et al.
IOVS 2005;46:4016-4023.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial to Determine the Effectiveness of Prism Spectacles for Patients With Age-Related Macular Degeneration
Smith et al.
Arch Ophthalmol 2005;123:1042-1050.
ABSTRACT | FULL TEXT  

Prevalence and Burden of Self-reported Blindness, Low Vision, and Visual Impairment in the French Community: A Nationwide Survey
Brezin et al.
Arch Ophthalmol 2005;123:1117-1124.
ABSTRACT | FULL TEXT  

Psychological Disturbance in Graves Ophthalmopathy
Farid et al.
Arch Ophthalmol 2005;123:491-496.
ABSTRACT | FULL TEXT  

Geographic Variation in the Prevalence of Macular Disease Among Elderly Medicare Beneficiaries in Kansas
Holcomb and Lin
Am. J. Public Health 2005;95:75-77.
ABSTRACT | FULL TEXT  

Self-management of Age-related Macular Degeneration at the 6-Month Follow-up: A Randomized Controlled Trial
Brody et al.
Arch Ophthalmol 2005;123:46-53.
ABSTRACT | FULL TEXT  

Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5
Submacular Surgery Trials Research Group
Arch Ophthalmol 2005;123:78-88.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: II. Quality-of-Life Findings From a Randomized Clinical Trial: SST Group H Trial: SST Report No. 10
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1616-1628.
ABSTRACT | FULL TEXT  

Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial
Reeves et al.
Br. J. Ophthalmol. 2004;88:1443-1449.
ABSTRACT | FULL TEXT  

Blindness, low vision, and other handicaps as risk factors attached to institutional residence
Brezin et al.
Br. J. Ophthalmol. 2004;88:1330-1337.
ABSTRACT | FULL TEXT  

Measurement of Health-Related Quality of Life in the National Emphysema Treatment Trial
Kaplan et al.
Chest 2004;126:781-789.
ABSTRACT | FULL TEXT  

Cost effectiveness of photodynamic therapy with verteporfin for age related macular degeneration: the UK case
Smith et al.
Br. J. Ophthalmol. 2004;88:1107-1112.
ABSTRACT | FULL TEXT  

Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer
Stevenson et al.
Br. J. Ophthalmol. 2004;88:1125-1130.
ABSTRACT | FULL TEXT  

The impact of diabetic retinopathy: perspectives from patient focus groups
Coyne et al.
Fam Pract 2004;21:447-453.
ABSTRACT | FULL TEXT  

When Treatment Fails: Caring for Patients With Visual Disability
Gieser
Arch Ophthalmol 2004;122:1208-1209.
FULL TEXT  

Relative Contributions of Reduced Vision and General Health to NEI-VFQ Scores in Patients With Neovascular Age-Related Macular Degeneration
Miskala et al.
Arch Ophthalmol 2004;122:758-766.
ABSTRACT | FULL TEXT  

Impact of an interdisciplinary low vision service on the quality of life of low vision patients
Hinds et al.
Br. J. Ophthalmol. 2003;87:1391-1396.
ABSTRACT | FULL TEXT  

How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?
Owen et al.
Br. J. Ophthalmol. 2003;87:312-317.
ABSTRACT | FULL TEXT  

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10
Clemons et al.
Arch Ophthalmol 2003;121:211-217.
ABSTRACT | FULL TEXT  

Quality of life with macular degeneration: perceptions of patients, clinicians, and community members
Stein et al.
Br. J. Ophthalmol. 2003;87:8-12.
ABSTRACT | FULL TEXT  

Self-management of Age-Related Macular Degeneration and Quality of Life: A Randomized Controlled Trial
Brody et al.
Arch Ophthalmol 2002;120:1477-1483.
ABSTRACT | FULL TEXT  

Effect of Depression on Vision Function in Age-Related Macular Degeneration
Rovner et al.
Arch Ophthalmol 2002;120:1041-1044.
ABSTRACT | FULL TEXT  

Perceived quality of health care in macular disease: a survey of members of the Macular Disease Society
Mitchell et al.
Br. J. Ophthalmol. 2002;86:777-781.
ABSTRACT | FULL TEXT  

Macular Pigment and Risk for Age-Related Macular Degeneration in Subjects from a Northern European Population
Beatty et al.
IOVS 2001;42:439-446.
ABSTRACT | FULL TEXT  

Vision and Low Self-Rated Health: The Blue Mountains Eye Study
Wang et al.
IOVS 2000;41:49-54.
ABSTRACT | FULL TEXT  

Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration
Chiquet et al.
Br. J. Ophthalmol. 1999;83:923-928.
ABSTRACT | FULL TEXT